Status:
COMPLETED
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
Lead Sponsor:
Indiana University
Conditions:
Iron Deficiency Anemia of Pregnancy
Iron Malabsorption
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
Iron deficiency is the most common cause of anemia in pregnancy worldwide, and, when severe, can have serious consequences for mothers and babies. While treatment of iron-deficiency anemia with iron s...
Detailed Description
Iron deficiency is the most common cause of anemia in pregnancy worldwide, and, when severe, can have serious consequences for mothers and babies. In the United States, anemia affects nearly 20% of pr...
Eligibility Criteria
Inclusion
- Iron-deficiency anemia (serum ferritin \<30 micrograms, normal hemoglobin electrophoresis, and hemoglobin \<10 mg/dL), planned delivery at Barnes-Jewish Hospital
Exclusion
- Non-iron-deficiency anemia, multiple gestation, prenatally diagnosed major fetal anomalies, known aneuploidy, planned delivery at other hospital, inability to obtain consent
Key Trial Info
Start Date :
April 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03438227
Start Date
April 15 2018
End Date
December 31 2019
Last Update
June 11 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University School of Medicine
Indianapolis, Indiana, United States, 46202
2
Center for Outpatient Health, Washington University in St. Louis
St Louis, Missouri, United States, 63110